HYDROXYBUTYLTIN OXIDE
General Information
Mainterm | HYDROXYBUTYLTIN OXIDE |
CAS Reg.No.(or other ID) | 2273-43-0 |
Regnum |
175.300 177.2420 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 16767 |
IUPAC Name | butyl-hydroxy-oxotin |
InChI | InChI=1S/C4H9.H2O.O.Sn/c1-3-4-2;;;/h1,3-4H2,2H3;1H2;;/q;;;+1/p-1 |
InChI Key | WIHMDCQAEONXND-UHFFFAOYSA-M |
Canonical SMILES | CCCC[Sn](=O)O |
Molecular Formula | C4H10O2Sn |
Wikipedia | butylstannonic acid |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 208.832 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 3 |
Complexity | 62.7 |
CACTVS Substructure Key Fingerprint | A A A D c c B g M A A A A A A A A A C A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G A A A C A A A C A C A A A A C A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 37.3 |
Monoisotopic Mass | 209.97 |
Exact Mass | 209.97 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 7 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9635 |
Human Intestinal Absorption | HIA+ | 0.9657 |
Caco-2 Permeability | Caco2+ | 0.5861 |
P-glycoprotein Substrate | Non-substrate | 0.7098 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9316 |
Non-inhibitor | 0.9941 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.9130 |
Distribution | ||
Subcellular localization | Mitochondria | 0.4988 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.7465 |
CYP450 2D6 Substrate | Non-substrate | 0.8260 |
CYP450 3A4 Substrate | Non-substrate | 0.6491 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7304 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8667 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8954 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8743 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9480 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9382 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8037 |
Non-inhibitor | 0.8933 | |
AMES Toxicity | Non AMES toxic | 0.6220 |
Carcinogens | Carcinogens | 0.5955 |
Fish Toxicity | Low FHMT | 0.8291 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.7017 |
Honey Bee Toxicity | High HBT | 0.6200 |
Biodegradation | Not ready biodegradable | 0.5268 |
Acute Oral Toxicity | III | 0.6820 |
Carcinogenicity (Three-class) | Non-required | 0.6379 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -1.7503 | LogS |
Caco-2 Permeability | 0.9676 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.7832 | LD50, mol/kg |
Fish Toxicity | 2.3494 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | -0.9745 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organic salts |
Class | Organic metal salts |
Subclass | Not available |
Intermediate Tree Nodes | Not available |
Direct Parent | Organic metal salts |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Organic metal salt - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Organic tin salt - Organometallic compound - Organic post-transition metal moeity - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as organic metal salts. These are organic salt compounds containing a metal atom in its ionic form. |
From ClassyFire